{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:19:38Z","timestamp":1794709178418,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022A1515012369"],"award-info":[{"award-number":["2022A1515012369"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370587"],"award-info":[{"award-number":["82370587"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100648"],"award-info":[{"award-number":["82100648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400663"],"award-info":[{"award-number":["82400663"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.metabol.2026.156779","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:37:52Z","timestamp":1789627072000},"page":"156779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Keratin 8 Destabilization via O-GlcNAcylation Promotes Insulin Resistance in metabolic dysfunction associated steatotic liver disease"],"prefix":"10.1016","volume":"185","author":[{"given":"Long","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congxiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bihui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2026.156779_bb0005","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.metabol.2026.156779_bb0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","article-title":"Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms","volume":"83","author":"Steinberg","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2026.156779_bb0015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2026.156779_bb0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41573-024-01084-2","article-title":"Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"24","author":"Do","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2026.156779_bb0025","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","article-title":"Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2026.156779_bb0030","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2026.156779_bb0035","doi-asserted-by":"crossref","first-page":"964","DOI":"10.4093\/dmj.2025.0644","article-title":"Hepatic insulin resistance and steatosis in metabolic dysfunction-associated steatotic liver disease: new insights into mechanisms and clinical implications","volume":"49","author":"Truong","year":"2025","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.metabol.2026.156779_bb0040","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","article-title":"Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease","volume":"36","author":"Bo","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2026.156779_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.metabol.2019.05.011","article-title":"Novel aspects of the role of the liver in carbohydrate metabolism","volume":"99","author":"Bergman","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156779_bb0050","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2015.01.012","article-title":"Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes","volume":"160","author":"Perry","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2026.156779_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155811","article-title":"Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth","volume":"154","author":"Dashti","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156779_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.155115","article-title":"Cytoskeleton alterations in non-alcoholic fatty liver disease","volume":"128","author":"Pessoa","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156779_bb0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1586\/egh.11.5","article-title":"The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthful","volume":"5","author":"Molnar","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2026.156779_bb0070","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83338","article-title":"Microtubule-mediated GLUT4 trafficking is disrupted in insulin-resistant skeletal muscle","volume":"12","author":"Knudsen","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.metabol.2026.156779_bb0075","first-page":"464","article-title":"Keratin 8 mutations were associated with susceptibility to chronic hepatitis B and related progression","volume":"221","author":"Ye","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.metabol.2026.156779_bb0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrm3753","article-title":"Post-translational modifications of intermediate filament proteins: mechanisms and functions","volume":"15","author":"Snider","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2026.156779_bb0085","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.3748\/wjg.v23.i22.4047","article-title":"Association of keratin 8\/18 variants with non-alcoholic fatty liver disease and insulin resistance in Chinese patients: a case-control study","volume":"23","author":"Li","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2026.156779_bb0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1096\/fj.15-277905","article-title":"Impact of keratin intermediate filaments on insulin-mediated glucose metabolism regulation in the liver and disease association","volume":"30","author":"Roux","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2026.156779_bb0095","doi-asserted-by":"crossref","first-page":"34062","DOI":"10.1074\/jbc.M109.098996","article-title":"O-GlcNAcylation determines the solubility, filament organization, and stability of keratins 8 and 18","volume":"285","author":"Srikanth","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156779_bb0100","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ncb0910-847","article-title":"Stressing the role of O-GlcNAc: linking cell survival to keratin modification","volume":"12","author":"Rotty","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2026.156779_bb0105","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1074\/jbc.270.20.11820","article-title":"Identification and mutational analysis of the glycosylation sites of human keratin 18","volume":"270","author":"Ku","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156779_bb0110","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hep.24376","article-title":"Endpoints and clinical trial design for nonalcoholic steatohepatitis","volume":"54","author":"Sanyal","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156779_bb0115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156779_bb0120","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1242\/jcs.00782","article-title":"Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury","volume":"116","author":"Tao","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.metabol.2026.156779_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn0050","article-title":"Targeting oxidized phospholipids by AAV-based gene therapy in mice with established hepatic steatosis prevents progression to fibrosis","volume":"8","author":"Upchurch","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.metabol.2026.156779_bb0130","article-title":"LIMA1 O-GlcNAcylation promotes hepatic lipid deposition through inducing \u03b2-catenin-regulated FASn expression in metabolic dysfunction-associated steatotic liver disease","volume":"12","author":"Yang","year":"2025","journal-title":"Adv Sci"},{"key":"10.1016\/j.metabol.2026.156779_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tem.2013.02.002","article-title":"Cracking the O-GlcNAc code in metabolism","volume":"24","author":"Ruan","year":"2013","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.metabol.2026.156779_bb0140","article-title":"O-GlcNAcylation: cellular physiology and therapeutic target for human diseases","volume":"2023","author":"Ye","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.metabol.2026.156779_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101776","article-title":"Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function","volume":"75","author":"Gonzalez-Rellan","year":"2023","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2026.156779_bb0150","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1038\/s41467-021-24301-7","article-title":"Hexosamine biosynthetic pathway and O-GlcNAc-processing enzymes regulate daily rhythms in protein O-GlcNAcylation","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2026.156779_bb0155","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/his.14631","article-title":"Utility of sonic hedgehog and keratin 8\/18 immunohistochemistry for detecting ballooned hepatocytes","volume":"8","author":"Kusano","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.metabol.2026.156779_bb0160","first-page":"C462","article-title":"\u03b2-Cell keratin 8 maintains islet mechanical integrity, mitochondrial ultrastructure, and \u03b2-cell glucose transporter 2 plasma membrane targeting","volume":"327","author":"Baghestani","year":"2024","journal-title":"Am J Phys Cell Phys"},{"key":"10.1016\/j.metabol.2026.156779_bb0165","doi-asserted-by":"crossref","first-page":"12003","DOI":"10.1074\/jbc.M116.728717","article-title":"Functional implications of O-GlcNAcylation-dependent phosphorylation at a proximal site on keratin 18","volume":"291","author":"Kakade","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156779_bb0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.200602146","article-title":"A disease- and phosphorylation-related nonmechanical function for keratin 8","volume":"174","author":"Ku","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1016\/j.metabol.2026.156779_bb0175","doi-asserted-by":"crossref","first-page":"10775","DOI":"10.1074\/jbc.M107623200","article-title":"Keratin 8 phosphorylation by p38 kinase regulates cellular keratin filament reorganization: modulation by a keratin 1-like disease causing mutation","volume":"277","author":"Ku","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156779_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154015","article-title":"Curcumin analog CUR5\u20138 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity","volume":"103","author":"Lee","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156779_bb0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.yexcr.2006.10.007","article-title":"Keratins modulate hepatic cell adhesion, size and G1\/S transition","volume":"313","author":"Galarneau","year":"2007","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.metabol.2026.156779_bb0190","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1096\/fj.201700036R","article-title":"Keratin 8\/18 regulation of insulin receptor signaling and trafficking in hepatocytes through a concerted phosphoinositide-dependent Akt and Rab5 modulation","volume":"31","author":"Roux","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2026.156779_bb0195","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/embor.2013.5","article-title":"The multifaceted role of mTORC1 in the control of lipid metabolism","volume":"14","author":"Ricoult","year":"2013","journal-title":"EMBO Rep"},{"key":"10.1016\/j.metabol.2026.156779_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf8271","article-title":"Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1","volume":"376","author":"Gosis","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.metabol.2026.156779_bb0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","article-title":"Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways","volume":"14","author":"Yecies","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2026.156779_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2023.102262","article-title":"How do disordered head domains assist in the assembly of intermediate filaments?","volume":"85","author":"Zhou","year":"2023","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.metabol.2026.156779_bb0215","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/hep.20277","article-title":"Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease","volume":"40","author":"Toivola","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156779_bb0220","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1101\/gad.7.7a.1191","article-title":"Mid-gestational lethality in mice lacking keratin 8","volume":"7","author":"Baribault","year":"1993","journal-title":"Genes Dev"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T01:33:45Z","timestamp":1794706425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526002921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":44,"alternative-id":["S0026049526002921"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156779","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Keratin 8 Destabilization via O-GlcNAcylation Promotes Insulin Resistance in metabolic dysfunction associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156779"}}